Deidi Strickland Bergestuen


    Publications 2015

    Boyar Cetinkaya R, Aagnes B, Thiis-Evensen E, Tretli S, Bergestuen DS, Hansen S (2015)
    Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
    Neuroendocrinology, 104 (1), 1-10
    DOI 10.1159/000442207, PubMed 26562558

    Publications 2014

    Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E (2014)
    Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Scand J Gastroenterol, 49 (6), 734-41
    DOI 10.3109/00365521.2014.903432, PubMed 24679166

    Toumpanakis C, Kim MK, Rinke A, Bergestuen DS, Thirlwell C, Khan MS, Salazar R, Oberg K (2014)
    Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors
    Neuroendocrinology, 99 (2), 63-74
    DOI 10.1159/000358727, PubMed 24458014

    Publications 2013

    Gedde-Dahl M, Thiis-Evensen E, Tjølsen AM, Mordal KS, Vatn M, Bergestuen DS (2013)
    Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
    Endocr Connect, 2 (1), 50-4
    DOI 10.1530/EC-12-0077, PubMed 23781318

    Publications 2011

    Haugaa KH, Bergestuen DS, Sahakyan LG, Skulstad H, Aakhus S, Thiis-Evensen E, Edvardsen T (2011)
    Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease
    J Am Soc Echocardiogr, 24 (6), 644-50
    DOI 10.1016/j.echo.2011.02.009, PubMed 21440415

    Publications 2010

    Bergestuen DS (2010)
    Studies on the epidemiology and fibrotic complications ofsmall intestinal neuroendocrine tumors
    In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 988, 1 b. (flere pag.)
    BIBSYS 102103720, ISBN 978-82-8072-497-7

    Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
    Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
    Neuroendocrinology, 92 (3), 168-77
    DOI 10.1159/000318014, PubMed 20720391

    Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, Thiis-Evensen E, Øie E, Aukrust P, Attramadal H, Edvardsen T (2010)
    Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
    BMC Cancer, 10, 6
    DOI 10.1186/1471-2407-10-6, PubMed 20053285

    Pomianowska E, Gladhaug IP, Grzyb K, Røsok BI, Edwin B, Bergestuen DS, Mathisen O (2010)
    Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems
    Scand J Gastroenterol, 45 (7-8), 971-9
    DOI 10.3109/00365521003782363, PubMed 20441530

    Publications 2009

    Bergestuen DA, Aakhus S (2009)
    [Heart disease with a rare cause]
    Tidsskr Nor Laegeforen, 129 (3), 191
    DOI 10.4045/tidsskr.08.0480, PubMed 19192507

    Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E (2009)
    Small intestinal neuroendocrine tumors: prognostic factors and survival
    Scand J Gastroenterol, 44 (9), 1084-91
    DOI 10.1080/00365520903082432, PubMed 19572232

    Page visits: 7111